Privi Speciality Chemicals DuPont analysis

Per cent unless marked ×
Tap a line for its trendLast 12Mto Sep 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
0.73×0.72×0.73×0.73×0.69×
0.94×0.88×0.79×0.64×0.40×
19.5%19.6%15.3%11.5%4.8%
0.86×0.86×0.82×0.74×0.70×
2.10×2.20×2.50×2.49×2.86×
24.3%23.4%18.0%10.0%2.7%
25.2%25.2%18.2%10.9%3.0%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

PRIVISCL₹3,296.30

Privi Speciality Chemicals Ltd.

· Chemicals
₹ CrorePeersAARTIINDRAINRALLISRCFNFLREFEXNEOGENLXCHEMMcap ₹12,876 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/09/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×0.690.730.730.720.73
Interest Burden (Pretax/EBIT) ×0.400.640.790.880.94
EBIT Margin %4.8211.5015.3119.6019.52
Asset Turnover ×0.700.740.820.860.86
Financial Leverage (Assets/Equity) ×2.862.492.502.202.10
ROE (5-step product, year-end total equity) %2.6510.0318.0023.3824.27
ROE (owners' profit / average owners' equity) %3.0010.8818.2225.1825.18
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.